TrialBritish journal of clinical pharmacology2022

Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study.

Titia Q Ruijs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.